Project
A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for PATZ1_KLF4
Z-value: 4.61
Motif logo
Transcription factors associated with PATZ1_KLF4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
|
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PATZ1 | hg19_v2_chr22_-_31742218_31742350 | 0.99 | 1.4e-02 | Click! |
| KLF4 | hg19_v2_chr9_-_110251836_110251927 | 0.37 | 6.3e-01 | Click! |
Activity profile of PATZ1_KLF4 motif
Sorted Z-values of PATZ1_KLF4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr9_+_130922537 | 8.81 |
ENST00000372994.1
|
C9orf16
|
chromosome 9 open reading frame 16 |
| chr8_-_145691031 | 7.30 |
ENST00000424149.2
ENST00000530637.1 ENST00000306145.5 |
CYHR1
|
cysteine/histidine-rich 1 |
| chr19_-_1863567 | 6.77 |
ENST00000250916.4
|
KLF16
|
Kruppel-like factor 16 |
| chr19_+_47778119 | 6.66 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
| chr11_+_64073022 | 6.62 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chr19_+_6373482 | 6.52 |
ENST00000596657.1
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli) |
| chr19_+_6373715 | 6.39 |
ENST00000599849.1
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli) |
| chr14_-_21566731 | 6.30 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr2_-_178129551 | 5.68 |
ENST00000430047.1
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
| chr14_+_105559784 | 5.61 |
ENST00000548104.1
|
RP11-44N21.1
|
RP11-44N21.1 |
| chr1_+_11333546 | 5.53 |
ENST00000376804.2
|
UBIAD1
|
UbiA prenyltransferase domain containing 1 |
| chr19_+_48673949 | 5.53 |
ENST00000328759.7
|
C19orf68
|
chromosome 19 open reading frame 68 |
| chr10_-_126849626 | 5.23 |
ENST00000530884.1
|
CTBP2
|
C-terminal binding protein 2 |
| chr19_-_6767516 | 5.12 |
ENST00000245908.6
|
SH2D3A
|
SH2 domain containing 3A |
| chrX_+_152990302 | 5.04 |
ENST00000218104.3
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
| chr16_-_28223229 | 4.86 |
ENST00000566073.1
|
XPO6
|
exportin 6 |
| chr17_-_79791118 | 4.82 |
ENST00000576431.1
ENST00000575061.1 ENST00000455127.2 ENST00000572645.1 ENST00000538396.1 ENST00000573478.1 |
FAM195B
|
family with sequence similarity 195, member B |
| chr19_+_54694119 | 4.82 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
| chr19_-_6767431 | 4.77 |
ENST00000437152.3
ENST00000597687.1 |
SH2D3A
|
SH2 domain containing 3A |
| chr19_+_50433476 | 4.71 |
ENST00000596658.1
|
ATF5
|
activating transcription factor 5 |
| chr19_+_51152702 | 4.64 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr7_+_97910962 | 4.59 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
| chr1_+_38273818 | 4.55 |
ENST00000373042.4
|
C1orf122
|
chromosome 1 open reading frame 122 |
| chr19_+_41305330 | 4.48 |
ENST00000593972.1
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
| chr22_+_43547937 | 4.48 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
| chr9_+_140500087 | 4.45 |
ENST00000371421.4
|
ARRDC1
|
arrestin domain containing 1 |
| chr6_+_33378517 | 4.40 |
ENST00000428274.1
|
PHF1
|
PHD finger protein 1 |
| chr11_+_394145 | 4.30 |
ENST00000528036.1
|
PKP3
|
plakophilin 3 |
| chr1_+_3689325 | 4.27 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
| chr12_+_57916584 | 4.26 |
ENST00000546632.1
ENST00000549623.1 ENST00000431731.2 |
MBD6
|
methyl-CpG binding domain protein 6 |
| chr19_+_34287174 | 4.21 |
ENST00000587559.1
ENST00000588637.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr11_-_560703 | 4.20 |
ENST00000441853.1
ENST00000329451.3 |
C11orf35
|
chromosome 11 open reading frame 35 |
| chr19_+_1104415 | 4.17 |
ENST00000585362.2
|
GPX4
|
glutathione peroxidase 4 |
| chr7_+_2671568 | 4.16 |
ENST00000258796.7
|
TTYH3
|
tweety family member 3 |
| chr16_+_29911666 | 4.12 |
ENST00000563177.1
ENST00000483405.1 |
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr8_+_145691411 | 4.12 |
ENST00000301332.2
|
KIFC2
|
kinesin family member C2 |
| chr7_+_73082152 | 4.11 |
ENST00000324941.4
ENST00000451519.1 |
VPS37D
|
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
| chr22_-_50746027 | 4.05 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
| chr19_-_9929708 | 4.04 |
ENST00000247977.4
ENST00000590277.1 ENST00000588922.1 ENST00000589626.1 ENST00000592067.1 ENST00000586469.1 |
FBXL12
|
F-box and leucine-rich repeat protein 12 |
| chr7_-_1067968 | 4.01 |
ENST00000412051.1
|
C7orf50
|
chromosome 7 open reading frame 50 |
| chr1_+_38273988 | 4.01 |
ENST00000446260.2
|
C1orf122
|
chromosome 1 open reading frame 122 |
| chr8_+_21906433 | 3.99 |
ENST00000522148.1
|
DMTN
|
dematin actin binding protein |
| chr5_-_180229791 | 3.99 |
ENST00000504671.1
ENST00000507384.1 |
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr14_-_21567009 | 3.95 |
ENST00000556174.1
ENST00000554478.1 ENST00000553980.1 ENST00000421093.2 |
ZNF219
|
zinc finger protein 219 |
| chr7_+_5322561 | 3.92 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
| chr19_-_913160 | 3.91 |
ENST00000361574.5
ENST00000587975.1 |
R3HDM4
|
R3H domain containing 4 |
| chr22_+_43547520 | 3.87 |
ENST00000337554.3
ENST00000396265.3 ENST00000583777.1 |
TSPO
|
translocator protein (18kDa) |
| chr22_-_50946113 | 3.85 |
ENST00000216080.5
ENST00000474879.2 ENST00000380796.3 |
LMF2
|
lipase maturation factor 2 |
| chr12_+_57916466 | 3.85 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
| chr19_-_47734448 | 3.84 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
| chr19_+_41284121 | 3.79 |
ENST00000594800.1
ENST00000357052.2 ENST00000602173.1 |
RAB4B
|
RAB4B, member RAS oncogene family |
| chr19_+_46009837 | 3.77 |
ENST00000589627.1
|
VASP
|
vasodilator-stimulated phosphoprotein |
| chr22_+_45098067 | 3.75 |
ENST00000336985.6
ENST00000403696.1 ENST00000457960.1 ENST00000361473.5 |
PRR5
PRR5-ARHGAP8
|
proline rich 5 (renal) PRR5-ARHGAP8 readthrough |
| chr7_-_100487280 | 3.74 |
ENST00000388761.2
|
UFSP1
|
UFM1-specific peptidase 1 (non-functional) |
| chr17_+_21188012 | 3.74 |
ENST00000529517.1
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr1_+_955448 | 3.72 |
ENST00000379370.2
|
AGRN
|
agrin |
| chr19_+_56652643 | 3.70 |
ENST00000586123.1
|
ZNF444
|
zinc finger protein 444 |
| chr14_+_105957402 | 3.69 |
ENST00000421892.1
ENST00000334656.7 ENST00000451719.1 ENST00000392522.3 ENST00000392523.4 ENST00000354560.6 ENST00000450383.1 |
C14orf80
|
chromosome 14 open reading frame 80 |
| chr11_+_66624527 | 3.67 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
| chr8_-_144691718 | 3.64 |
ENST00000377579.3
ENST00000433751.1 ENST00000220966.6 |
PYCRL
|
pyrroline-5-carboxylate reductase-like |
| chr8_-_145754428 | 3.63 |
ENST00000527462.1
ENST00000313465.5 ENST00000524821.1 |
C8orf82
|
chromosome 8 open reading frame 82 |
| chr19_-_291365 | 3.63 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr9_+_139377947 | 3.63 |
ENST00000354376.1
|
C9orf163
|
chromosome 9 open reading frame 163 |
| chrX_+_153238220 | 3.57 |
ENST00000425274.1
|
TMEM187
|
transmembrane protein 187 |
| chr8_+_144679984 | 3.57 |
ENST00000504548.2
ENST00000321385.3 |
TIGD5
|
tigger transposable element derived 5 |
| chr9_-_131486367 | 3.56 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
| chr14_+_104604916 | 3.52 |
ENST00000423312.2
|
KIF26A
|
kinesin family member 26A |
| chr19_-_46272462 | 3.51 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
| chr21_+_46825032 | 3.49 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr11_-_65686586 | 3.49 |
ENST00000438576.2
|
C11orf68
|
chromosome 11 open reading frame 68 |
| chr16_+_770975 | 3.46 |
ENST00000569529.1
ENST00000564000.1 ENST00000219535.3 |
FAM173A
|
family with sequence similarity 173, member A |
| chr21_+_47401650 | 3.46 |
ENST00000361866.3
|
COL6A1
|
collagen, type VI, alpha 1 |
| chr12_+_132379160 | 3.42 |
ENST00000321867.4
|
ULK1
|
unc-51 like autophagy activating kinase 1 |
| chr11_+_393428 | 3.41 |
ENST00000533249.1
ENST00000527442.1 |
PKP3
|
plakophilin 3 |
| chr17_-_18266818 | 3.38 |
ENST00000583780.1
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble) |
| chr19_+_56653064 | 3.35 |
ENST00000593100.1
|
ZNF444
|
zinc finger protein 444 |
| chr1_+_1370903 | 3.35 |
ENST00000338660.5
ENST00000404702.3 ENST00000476993.1 ENST00000471398.1 |
VWA1
|
von Willebrand factor A domain containing 1 |
| chr4_-_1723040 | 3.35 |
ENST00000382936.3
ENST00000536901.1 ENST00000303277.2 |
TMEM129
|
transmembrane protein 129 |
| chr14_-_102976135 | 3.35 |
ENST00000560748.1
|
ANKRD9
|
ankyrin repeat domain 9 |
| chr8_-_144897549 | 3.34 |
ENST00000356994.2
ENST00000320476.3 |
SCRIB
|
scribbled planar cell polarity protein |
| chr9_+_136325089 | 3.33 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
| chr19_+_3539152 | 3.32 |
ENST00000329493.5
|
C19orf71
|
chromosome 19 open reading frame 71 |
| chr16_+_29911864 | 3.32 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr5_+_149865377 | 3.31 |
ENST00000522491.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
| chr8_-_142318398 | 3.29 |
ENST00000520137.1
|
SLC45A4
|
solute carrier family 45, member 4 |
| chr16_+_640055 | 3.28 |
ENST00000568586.1
ENST00000538492.1 ENST00000248139.3 |
RAB40C
|
RAB40C, member RAS oncogene family |
| chr11_-_65686496 | 3.28 |
ENST00000449692.3
|
C11orf68
|
chromosome 11 open reading frame 68 |
| chr16_-_89768097 | 3.28 |
ENST00000289805.5
ENST00000335360.7 |
SPATA2L
|
spermatogenesis associated 2-like |
| chr17_-_76356148 | 3.26 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
| chr17_+_72772621 | 3.26 |
ENST00000335464.5
ENST00000417024.2 ENST00000578764.1 ENST00000582773.1 ENST00000582330.1 |
TMEM104
|
transmembrane protein 104 |
| chr20_+_33464368 | 3.26 |
ENST00000484354.1
ENST00000493805.2 ENST00000473172.1 |
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr19_+_41305612 | 3.25 |
ENST00000594380.1
ENST00000593397.1 ENST00000601733.1 |
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
| chr19_+_1905365 | 3.24 |
ENST00000329478.2
ENST00000602400.1 ENST00000409472.1 |
ADAT3
SCAMP4
|
adenosine deaminase, tRNA-specific 3 secretory carrier membrane protein 4 |
| chr19_+_56111680 | 3.23 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
| chr9_+_95858485 | 3.23 |
ENST00000375464.2
|
C9orf89
|
chromosome 9 open reading frame 89 |
| chr19_-_38878632 | 3.22 |
ENST00000586599.1
ENST00000334928.6 ENST00000587676.1 |
GGN
|
gametogenetin |
| chr5_-_180237082 | 3.22 |
ENST00000506889.1
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr16_-_3030407 | 3.21 |
ENST00000431515.2
ENST00000574385.1 ENST00000576268.1 ENST00000574730.1 ENST00000575632.1 ENST00000573944.1 ENST00000262300.8 |
PKMYT1
|
protein kinase, membrane associated tyrosine/threonine 1 |
| chr15_+_63569785 | 3.21 |
ENST00000380343.4
ENST00000560353.1 |
APH1B
|
APH1B gamma secretase subunit |
| chr19_-_663277 | 3.20 |
ENST00000292363.5
|
RNF126
|
ring finger protein 126 |
| chr11_+_2923423 | 3.18 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_+_50016411 | 3.18 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chr19_-_55791431 | 3.16 |
ENST00000593263.1
ENST00000376343.3 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
| chr16_+_765092 | 3.16 |
ENST00000568223.2
|
METRN
|
meteorin, glial cell differentiation regulator |
| chr19_-_17356697 | 3.16 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
| chr14_-_105767598 | 3.14 |
ENST00000548421.1
|
BRF1
|
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
| chr16_+_2570340 | 3.14 |
ENST00000568263.1
ENST00000293971.6 ENST00000302956.4 ENST00000413459.3 ENST00000566706.1 ENST00000569879.1 |
AMDHD2
|
amidohydrolase domain containing 2 |
| chr17_-_72869086 | 3.14 |
ENST00000581530.1
ENST00000420580.2 ENST00000455107.2 ENST00000413947.2 ENST00000581219.1 ENST00000582944.1 |
FDXR
|
ferredoxin reductase |
| chr19_+_676385 | 3.13 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
| chr22_+_43547877 | 3.13 |
ENST00000428336.1
|
TSPO
|
translocator protein (18kDa) |
| chr20_+_62152077 | 3.13 |
ENST00000370179.3
ENST00000370177.1 |
PPDPF
|
pancreatic progenitor cell differentiation and proliferation factor |
| chr9_+_130159471 | 3.13 |
ENST00000419917.1
|
SLC2A8
|
solute carrier family 2 (facilitated glucose transporter), member 8 |
| chr16_+_2563871 | 3.13 |
ENST00000330398.4
ENST00000568562.1 ENST00000569317.1 |
ATP6V0C
ATP6C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c Uncharacterized protein |
| chr19_+_7985198 | 3.11 |
ENST00000221573.6
ENST00000595637.1 |
SNAPC2
|
small nuclear RNA activating complex, polypeptide 2, 45kDa |
| chr11_-_507184 | 3.11 |
ENST00000533410.1
ENST00000354420.2 ENST00000397604.3 ENST00000531149.1 ENST00000356187.5 |
RNH1
|
ribonuclease/angiogenin inhibitor 1 |
| chr8_+_1711918 | 3.10 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
| chr19_-_47551836 | 3.10 |
ENST00000253047.6
|
TMEM160
|
transmembrane protein 160 |
| chr12_-_6982442 | 3.09 |
ENST00000523102.1
ENST00000524270.1 ENST00000519357.1 |
SPSB2
|
splA/ryanodine receptor domain and SOCS box containing 2 |
| chr20_-_3154162 | 3.09 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
| chr16_+_30935418 | 3.08 |
ENST00000338343.4
|
FBXL19
|
F-box and leucine-rich repeat protein 19 |
| chr11_+_71934962 | 3.07 |
ENST00000543234.1
|
INPPL1
|
inositol polyphosphate phosphatase-like 1 |
| chr19_+_47759716 | 3.07 |
ENST00000221922.6
|
CCDC9
|
coiled-coil domain containing 9 |
| chr16_+_776936 | 3.07 |
ENST00000549114.1
ENST00000341413.4 ENST00000562187.1 ENST00000564537.1 |
HAGHL
|
hydroxyacylglutathione hydrolase-like |
| chr4_-_2936514 | 3.04 |
ENST00000508221.1
ENST00000507555.1 ENST00000355443.4 |
MFSD10
|
major facilitator superfamily domain containing 10 |
| chr6_-_31697563 | 3.03 |
ENST00000375789.2
ENST00000416410.1 |
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
| chr7_+_2559399 | 3.02 |
ENST00000222725.5
ENST00000359574.3 |
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr20_-_32031680 | 3.02 |
ENST00000217381.2
|
SNTA1
|
syntrophin, alpha 1 |
| chr16_+_2933209 | 3.00 |
ENST00000293981.6
|
FLYWCH2
|
FLYWCH family member 2 |
| chr22_+_31031639 | 2.99 |
ENST00000343605.4
ENST00000300385.8 |
SLC35E4
|
solute carrier family 35, member E4 |
| chr17_-_40828969 | 2.99 |
ENST00000591022.1
ENST00000587627.1 ENST00000293349.6 |
PLEKHH3
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
| chr4_-_2935674 | 2.99 |
ENST00000514800.1
|
MFSD10
|
major facilitator superfamily domain containing 10 |
| chr13_-_110438914 | 2.98 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr6_+_33378738 | 2.98 |
ENST00000374512.3
ENST00000374516.3 |
PHF1
|
PHD finger protein 1 |
| chr17_-_7307358 | 2.97 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr11_-_62313090 | 2.96 |
ENST00000528508.1
ENST00000533365.1 |
AHNAK
|
AHNAK nucleoprotein |
| chr22_-_50970506 | 2.95 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr19_-_54693521 | 2.95 |
ENST00000391754.1
ENST00000245615.1 ENST00000431666.2 |
MBOAT7
|
membrane bound O-acyltransferase domain containing 7 |
| chr16_+_691792 | 2.95 |
ENST00000307650.4
|
FAM195A
|
family with sequence similarity 195, member A |
| chr1_+_38273419 | 2.95 |
ENST00000468084.1
|
C1orf122
|
chromosome 1 open reading frame 122 |
| chr9_+_140317802 | 2.94 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr17_-_72869140 | 2.94 |
ENST00000583917.1
ENST00000293195.5 ENST00000442102.2 |
FDXR
|
ferredoxin reductase |
| chr4_+_76649753 | 2.93 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
| chr11_-_62380199 | 2.92 |
ENST00000419857.1
ENST00000394773.2 |
EML3
|
echinoderm microtubule associated protein like 3 |
| chr9_+_139886846 | 2.91 |
ENST00000371620.3
|
C9orf142
|
chromosome 9 open reading frame 142 |
| chr3_-_128840604 | 2.91 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
| chr19_-_14201776 | 2.90 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr11_+_2923619 | 2.90 |
ENST00000380574.1
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_-_50381606 | 2.90 |
ENST00000391830.1
|
AKT1S1
|
AKT1 substrate 1 (proline-rich) |
| chr8_-_144815966 | 2.88 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
| chr8_+_145064233 | 2.88 |
ENST00000529301.1
ENST00000395068.4 |
GRINA
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
| chrX_-_153707246 | 2.88 |
ENST00000407062.1
|
LAGE3
|
L antigen family, member 3 |
| chr16_-_2155399 | 2.88 |
ENST00000567946.1
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant) |
| chr19_-_4065730 | 2.87 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
| chr16_+_3070313 | 2.87 |
ENST00000326577.4
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
| chr2_+_219264466 | 2.85 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr1_-_41328018 | 2.85 |
ENST00000372638.2
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
| chr19_+_15218180 | 2.84 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
| chr8_+_145734433 | 2.83 |
ENST00000301327.4
|
MFSD3
|
major facilitator superfamily domain containing 3 |
| chr19_+_50879705 | 2.82 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
| chr22_-_19109901 | 2.82 |
ENST00000545799.1
ENST00000537045.1 ENST00000263196.7 |
DGCR2
|
DiGeorge syndrome critical region gene 2 |
| chr14_+_105219437 | 2.82 |
ENST00000329967.6
ENST00000347067.5 ENST00000553810.1 |
SIVA1
|
SIVA1, apoptosis-inducing factor |
| chr16_+_3019309 | 2.81 |
ENST00000576565.1
|
PAQR4
|
progestin and adipoQ receptor family member IV |
| chrX_+_153607557 | 2.80 |
ENST00000369842.4
ENST00000369835.3 |
EMD
|
emerin |
| chr11_+_560956 | 2.79 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
| chr3_+_19988736 | 2.79 |
ENST00000443878.1
|
RAB5A
|
RAB5A, member RAS oncogene family |
| chr17_-_79520135 | 2.78 |
ENST00000541246.1
ENST00000544302.1 |
C17orf70
|
chromosome 17 open reading frame 70 |
| chr1_-_45140074 | 2.78 |
ENST00000420706.1
ENST00000372235.3 ENST00000372242.3 ENST00000372243.3 ENST00000372244.3 |
TMEM53
|
transmembrane protein 53 |
| chr17_+_80186273 | 2.77 |
ENST00000584689.1
ENST00000392341.1 ENST00000583237.1 |
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
| chr8_-_144679602 | 2.77 |
ENST00000526710.1
|
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
| chr9_+_139249228 | 2.76 |
ENST00000392944.1
|
GPSM1
|
G-protein signaling modulator 1 |
| chr17_+_78075361 | 2.75 |
ENST00000577106.1
ENST00000390015.3 |
GAA
|
glucosidase, alpha; acid |
| chr22_-_30783075 | 2.73 |
ENST00000215798.6
|
RNF215
|
ring finger protein 215 |
| chr10_-_81932771 | 2.71 |
ENST00000437799.1
|
ANXA11
|
annexin A11 |
| chr16_+_88519669 | 2.71 |
ENST00000319555.3
|
ZFPM1
|
zinc finger protein, FOG family member 1 |
| chr17_-_17726907 | 2.71 |
ENST00000423161.3
|
SREBF1
|
sterol regulatory element binding transcription factor 1 |
| chr19_+_14544099 | 2.71 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
| chr19_-_7990991 | 2.70 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr17_+_17206635 | 2.70 |
ENST00000389022.4
|
NT5M
|
5',3'-nucleotidase, mitochondrial |
| chr16_-_1020954 | 2.69 |
ENST00000543238.1
ENST00000539379.1 ENST00000399843.2 ENST00000262301.11 |
LMF1
|
lipase maturation factor 1 |
| chr5_+_149865838 | 2.69 |
ENST00000519157.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
| chrX_-_153707545 | 2.68 |
ENST00000357360.4
|
LAGE3
|
L antigen family, member 3 |
| chr17_+_73521763 | 2.68 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
| chr22_+_50946645 | 2.68 |
ENST00000420993.2
ENST00000395698.3 ENST00000395701.3 ENST00000523045.1 ENST00000299821.11 |
NCAPH2
|
non-SMC condensin II complex, subunit H2 |
| chr20_-_23618582 | 2.67 |
ENST00000398411.1
ENST00000376925.3 |
CST3
|
cystatin C |
| chr6_-_31697977 | 2.67 |
ENST00000375787.2
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
| chr16_-_3030283 | 2.67 |
ENST00000572619.1
ENST00000574415.1 ENST00000440027.2 ENST00000572059.1 |
PKMYT1
|
protein kinase, membrane associated tyrosine/threonine 1 |
| chr1_+_1260147 | 2.66 |
ENST00000343938.4
|
GLTPD1
|
glycolipid transfer protein domain containing 1 |
| chr1_-_36789755 | 2.66 |
ENST00000270824.1
|
EVA1B
|
eva-1 homolog B (C. elegans) |
| chr21_-_45759250 | 2.65 |
ENST00000397956.3
ENST00000339818.4 ENST00000325223.7 |
C21orf2
|
chromosome 21 open reading frame 2 |
| chr11_+_65657875 | 2.64 |
ENST00000312579.2
|
CCDC85B
|
coiled-coil domain containing 85B |
| chr19_-_51014588 | 2.64 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
| chr19_-_51014345 | 2.64 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
| chr8_+_22446763 | 2.62 |
ENST00000450780.2
ENST00000430850.2 ENST00000447849.1 |
AC037459.4
|
Uncharacterized protein |
| chr1_-_15850676 | 2.62 |
ENST00000440484.1
ENST00000333868.5 |
CASP9
|
caspase 9, apoptosis-related cysteine peptidase |
| chr16_-_1821721 | 2.61 |
ENST00000219302.3
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3 |
| chr11_-_805224 | 2.61 |
ENST00000347755.5
|
PIDD
|
p53-induced death domain protein |
| chr11_+_2923499 | 2.61 |
ENST00000449793.2
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr9_+_130159504 | 2.59 |
ENST00000373352.1
ENST00000373360.3 |
SLC2A8
|
solute carrier family 2 (facilitated glucose transporter), member 8 |
| chr8_-_145669791 | 2.59 |
ENST00000409379.3
|
TONSL
|
tonsoku-like, DNA repair protein |
| chr11_+_64053311 | 2.58 |
ENST00000540370.1
|
GPR137
|
G protein-coupled receptor 137 |
Network of associatons between targets according to the STRING database.
First level regulatory network of PATZ1_KLF4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.2 | 6.5 | GO:0090187 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 2.1 | 12.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 2.1 | 6.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 2.0 | 7.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.9 | 11.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 1.7 | 7.0 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.7 | 15.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.6 | 4.7 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.5 | 5.9 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 1.4 | 7.2 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.4 | 5.5 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 1.3 | 7.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 1.3 | 5.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 1.2 | 3.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.2 | 11.9 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.2 | 8.2 | GO:0046618 | drug export(GO:0046618) |
| 1.1 | 3.4 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 1.1 | 4.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.1 | 4.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 1.1 | 4.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 1.1 | 13.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.1 | 7.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 1.0 | 4.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 1.0 | 7.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.0 | 1.0 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 1.0 | 3.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 1.0 | 6.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 1.0 | 2.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.0 | 2.9 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.0 | 2.9 | GO:0048627 | myoblast development(GO:0048627) |
| 0.9 | 3.8 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.9 | 0.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.9 | 3.7 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.9 | 3.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.9 | 2.8 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.9 | 0.9 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.9 | 3.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.9 | 2.7 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.9 | 3.6 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.9 | 3.6 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.9 | 0.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.9 | 1.7 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.9 | 2.6 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.9 | 2.6 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.9 | 3.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.9 | 1.7 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.8 | 2.5 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.8 | 7.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.8 | 0.8 | GO:0031063 | regulation of histone deacetylation(GO:0031063) regulation of protein deacetylation(GO:0090311) |
| 0.8 | 2.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.8 | 4.9 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.8 | 4.0 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.8 | 2.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 0.8 | 3.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.8 | 2.4 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.8 | 2.3 | GO:1990575 | mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 0.8 | 0.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.8 | 4.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.8 | 0.8 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.8 | 0.8 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.8 | 3.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.8 | 4.5 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.7 | 2.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.7 | 2.9 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.7 | 1.5 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.7 | 5.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.7 | 5.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.7 | 3.6 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.7 | 0.7 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.7 | 1.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.7 | 2.8 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.7 | 5.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.7 | 2.1 | GO:0061760 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.7 | 3.5 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.7 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.7 | 2.1 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.7 | 2.8 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.7 | 4.8 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.7 | 2.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.7 | 2.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.7 | 0.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) oncogene-induced cell senescence(GO:0090402) |
| 0.7 | 2.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.7 | 0.7 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.7 | 2.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.7 | 3.4 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.7 | 4.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.7 | 2.7 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.7 | 5.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.7 | 6.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.7 | 2.0 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.7 | 2.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.7 | 2.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.7 | 2.0 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.7 | 6.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.7 | 2.0 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.7 | 0.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.7 | 2.6 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.6 | 5.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.6 | 6.4 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.6 | 4.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.6 | 3.8 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.6 | 1.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.6 | 1.2 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.6 | 5.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.6 | 2.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.6 | 1.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.6 | 6.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.6 | 4.2 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.6 | 3.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.6 | 3.0 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.6 | 11.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.6 | 3.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 | 1.8 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.6 | 7.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.6 | 9.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.6 | 6.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.6 | 1.7 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.6 | 1.2 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.6 | 1.1 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.6 | 1.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.6 | 3.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.6 | 2.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.6 | 1.7 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.5 | 3.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 4.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.5 | 1.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 | 1.6 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.5 | 0.5 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
| 0.5 | 1.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.5 | 2.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.5 | 3.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.5 | 3.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.5 | 2.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.5 | 6.8 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.5 | 2.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.5 | 1.6 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.5 | 1.6 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.5 | 0.5 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.5 | 1.6 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.5 | 8.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.5 | 1.6 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.5 | 1.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.5 | 11.8 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.5 | 2.0 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.5 | 5.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.5 | 3.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.5 | 1.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.5 | 1.5 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.5 | 4.0 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
| 0.5 | 1.5 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.5 | 0.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.5 | 2.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.5 | 1.5 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.5 | 8.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.5 | 1.5 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.5 | 4.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.5 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
| 0.5 | 2.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 | 2.4 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.5 | 3.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 | 1.4 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.5 | 2.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.5 | 2.9 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.5 | 1.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.5 | 0.9 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.5 | 0.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.5 | 1.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.5 | 0.5 | GO:0060022 | hard palate development(GO:0060022) |
| 0.5 | 8.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.5 | 1.4 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.5 | 1.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.5 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 | 0.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.5 | 1.4 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.4 | 3.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.4 | 3.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.4 | 14.5 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.4 | 0.9 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.4 | 5.7 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.4 | 1.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.4 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.4 | 3.0 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
| 0.4 | 1.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.4 | 2.2 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.4 | 1.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.4 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.4 | 1.3 | GO:0060929 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.4 | 0.4 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.4 | 0.4 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
| 0.4 | 0.8 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.4 | 0.8 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.4 | 0.4 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.4 | 2.5 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.4 | 1.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.4 | 3.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.4 | 3.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.4 | 1.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.4 | 1.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.4 | 3.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 0.8 | GO:0075528 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.4 | 2.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 5.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.4 | 1.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.4 | 1.6 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.4 | 1.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 | 7.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.4 | 2.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.4 | 1.6 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.4 | 2.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.4 | 1.6 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.4 | 1.2 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.4 | 0.8 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.4 | 2.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.4 | 0.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 3.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.4 | 2.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 | 9.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.4 | 2.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 | 2.3 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.4 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.4 | 6.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.4 | 1.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.4 | 1.5 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 | 2.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.4 | 0.7 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.4 | 1.1 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.4 | 0.4 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.4 | 3.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.4 | 8.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 4.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 1.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.4 | 1.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 | 1.8 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.4 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.4 | 2.2 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.4 | 4.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.4 | 1.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.4 | 2.9 | GO:0045007 | depurination(GO:0045007) |
| 0.4 | 0.4 | GO:0097017 | renal protein absorption(GO:0097017) |
| 0.4 | 2.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.4 | 1.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.4 | 1.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 | 6.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 1.4 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.4 | 2.5 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.4 | 0.7 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 | 1.8 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.4 | 3.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.4 | 3.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 | 1.0 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 | 1.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 1.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 | 1.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 | 2.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 | 1.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 | 1.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 2.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 3.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 | 1.0 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.3 | 1.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.3 | 1.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 7.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.3 | 1.0 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.3 | 1.4 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.3 | 1.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.3 | 1.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 | 0.3 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
| 0.3 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 1.0 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.3 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 1.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 | 2.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.3 | 2.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 | 4.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 3.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.3 | 2.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.3 | 1.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 | 1.9 | GO:0030421 | defecation(GO:0030421) |
| 0.3 | 0.3 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.3 | 3.5 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.3 | 1.0 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 0.9 | GO:1905203 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
| 0.3 | 1.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.3 | 1.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.3 | 1.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.3 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.3 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 | 2.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 | 0.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.3 | 0.9 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.3 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.3 | 4.9 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.3 | 0.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 | 4.6 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.3 | 12.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 | 1.2 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.3 | 2.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 | 0.9 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.3 | 2.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.3 | 3.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 0.3 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.3 | 8.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 | 0.9 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.3 | 1.8 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.3 | 2.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 0.3 | GO:0072007 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
| 0.3 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 | 3.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 | 0.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.3 | 0.6 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.3 | 1.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 | 0.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.3 | 1.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.3 | 0.9 | GO:0070446 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.3 | 1.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 | 3.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.3 | 1.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.3 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.3 | 0.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 0.9 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 0.6 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
| 0.3 | 1.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 | 1.1 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.3 | 1.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.3 | 0.3 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 0.3 | 1.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 | 1.4 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 0.8 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 | 0.8 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 | 0.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.3 | 0.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.3 | 6.8 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.3 | 4.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 | 0.8 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.3 | 0.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 5.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.3 | 1.6 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.3 | 3.5 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 2.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.3 | 9.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 2.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.3 | 0.5 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.3 | 4.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.3 | 0.5 | GO:0007569 | cell aging(GO:0007569) |
| 0.3 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.3 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 2.6 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.3 | 2.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.3 | 0.5 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.3 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.3 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 | 4.1 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 2.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.3 | 2.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 | 3.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.3 | 3.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.3 | 0.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 | 0.5 | GO:0060914 | heart formation(GO:0060914) |
| 0.3 | 2.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.3 | 6.3 | GO:0015893 | drug transport(GO:0015893) |
| 0.3 | 0.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 | 0.3 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 0.3 | 0.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 0.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 | 3.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 3.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 4.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.2 | 1.0 | GO:0051340 | regulation of ligase activity(GO:0051340) |
| 0.2 | 1.7 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.2 | 0.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.2 | 1.0 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.2 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
| 0.2 | 1.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.2 | 1.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.2 | 9.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.2 | 1.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 | 1.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 1.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.2 | 2.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 1.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 1.0 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 3.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
| 0.2 | 0.2 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.2 | 0.7 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 | 1.0 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 0.7 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.2 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 3.8 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 | 0.9 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 3.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 0.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 0.7 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.2 | 0.7 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.2 | 0.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.2 | 1.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 | 0.7 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 | 0.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.2 | 0.5 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.2 | 1.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 3.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 1.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.2 | 0.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 | 0.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 | 0.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.2 | 0.7 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.2 | 1.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 2.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.2 | 0.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 0.7 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
| 0.2 | 0.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 | 2.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 1.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 0.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 3.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.2 | 4.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.2 | 1.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 0.6 | GO:0060629 | meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
| 0.2 | 2.6 | GO:0003096 | renal sodium ion transport(GO:0003096) |
| 0.2 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.2 | 1.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.2 | 1.5 | GO:0042262 | DNA protection(GO:0042262) |
| 0.2 | 5.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 | 0.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.2 | 2.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.2 | 1.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 0.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 | 1.2 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.2 | 0.6 | GO:0002368 | B cell cytokine production(GO:0002368) |
| 0.2 | 2.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 2.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.2 | 1.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 2.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.2 | 1.4 | GO:0032329 | serine transport(GO:0032329) |
| 0.2 | 0.2 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 | 2.8 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 0.8 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.2 | 2.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.2 | 0.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.2 | 1.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.2 | 1.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 | 0.4 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 | 0.2 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 | 2.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 2.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 4.4 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.2 | 0.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.2 | 1.2 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.2 | 1.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.2 | 1.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 1.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 1.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 2.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 | 1.5 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.2 | 1.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.2 | 1.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.2 | 0.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.2 | 1.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.2 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.2 | 0.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 4.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.2 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.2 | 3.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.2 | 0.6 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.2 | 5.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.2 | 1.1 | GO:0071362 | cellular response to ether(GO:0071362) |
| 0.2 | 0.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.7 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.2 | 2.0 | GO:0015866 | ADP transport(GO:0015866) |
| 0.2 | 2.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 0.4 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.2 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.2 | 2.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.2 | 5.0 | GO:0097502 | mannosylation(GO:0097502) |
| 0.2 | 1.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.2 | 3.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.2 | 7.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.2 | 5.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 0.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
| 0.2 | 0.7 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 1.1 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.2 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.2 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 5.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 0.2 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 3.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 0.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 | 1.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.2 | 2.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 0.2 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.2 | 0.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.2 | 0.5 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 1.4 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 10.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.2 | 1.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 | 0.2 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
| 0.2 | 0.7 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.2 | 3.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.2 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 | 0.3 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 0.2 | 2.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 0.7 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.2 | 1.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.2 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.2 | 2.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.2 | 0.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 | 4.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.5 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
| 0.2 | 2.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.2 | 6.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.2 | 1.0 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 | 1.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.2 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 2.0 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.2 | 4.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.2 | 0.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.2 | 3.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 | 3.3 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 1.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.2 | 1.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 | 1.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.2 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 0.6 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 0.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 | 1.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 0.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.2 | 0.8 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.2 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 2.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 | 0.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 3.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.2 | 0.5 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 | 1.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 | 0.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 | 0.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 1.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 0.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.2 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 0.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 | 0.2 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.2 | 0.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.2 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 0.9 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 | 2.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.9 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 | 0.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.1 | 3.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 1.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 0.3 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.1 | 1.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 0.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
| 0.1 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 0.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 | 1.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.1 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 | 3.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.1 | 1.0 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
| 0.1 | 1.4 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 0.7 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.1 | 2.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 3.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 2.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 2.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 | 1.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.1 | 0.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 1.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 3.5 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 | 0.7 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.1 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 | 0.3 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 | 1.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 0.5 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.1 | 0.1 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.1 | 0.8 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.7 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 0.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
| 0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 | 0.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 2.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.1 | 1.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.8 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.1 | 0.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 | 0.4 | GO:0019075 | virus maturation(GO:0019075) |
| 0.1 | 0.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 1.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.1 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.1 | 1.6 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.1 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
| 0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 2.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.1 | 3.4 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.4 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 1.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.5 | GO:0046385 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
| 0.1 | 0.3 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 0.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 | 2.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 4.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 0.5 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.1 | 0.5 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 | 1.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 0.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.1 | 1.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.1 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 0.8 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 1.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.3 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 1.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 | 0.5 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.6 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.1 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 | 0.5 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) |
| 0.1 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 | 1.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 1.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 3.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.4 | GO:0035524 | L-alanine transport(GO:0015808) proline transmembrane transport(GO:0035524) |
| 0.1 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.1 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
| 0.1 | 0.4 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
| 0.1 | 0.2 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
| 0.1 | 1.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.9 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 0.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.1 | 0.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 1.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.1 | 0.6 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.6 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 1.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 3.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 3.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.2 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.1 | 0.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 | 0.4 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.1 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 | 0.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 1.1 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.1 | 1.8 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 | 0.7 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.1 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.1 | 0.5 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 | 0.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.1 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 1.7 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.1 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.2 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
| 0.1 | 0.1 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 | 0.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 1.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 | 0.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 0.3 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.9 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 | 0.5 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.5 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
| 0.1 | 1.1 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
| 0.1 | 0.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.9 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.1 | 0.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.1 | 2.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 | 0.3 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
| 0.1 | 0.4 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 1.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 | 0.3 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.1 | 0.1 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.1 | 0.3 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.1 | 0.1 | GO:1901204 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.1 | 11.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 1.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 0.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 1.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 1.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 0.7 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.1 | 0.6 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.1 | 6.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 | 1.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.8 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.1 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.1 | 1.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 | 0.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 1.9 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 | 0.4 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 | 0.1 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.1 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 0.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.1 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
| 0.1 | 0.4 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.1 | 0.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 1.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.9 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 0.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.1 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 | 0.3 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 | 0.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 5.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
| 0.1 | 0.5 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 | 0.3 | GO:0035570 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.1 | 0.8 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.1 | 0.3 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.1 | 3.8 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
| 0.1 | 0.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 | 1.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 5.7 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 0.4 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.7 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.1 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.1 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 | 0.4 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.4 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 | 0.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.1 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.6 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 0.6 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
| 0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.1 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.1 | 1.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 0.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 1.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 1.5 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 | 1.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.1 | 0.3 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.1 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 5.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 1.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.8 | GO:0030004 | cellular monovalent inorganic cation homeostasis(GO:0030004) |
| 0.1 | 0.2 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 1.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 | 3.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.1 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) positive regulation of vascular wound healing(GO:0035470) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.1 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.2 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.1 | 2.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.1 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 1.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 1.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 0.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 0.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 1.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.9 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.1 | 0.1 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.1 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 0.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 0.4 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.1 | 0.1 | GO:0060922 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.1 | 0.4 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
| 0.1 | 1.0 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.1 | 0.9 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 | 0.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 | 1.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
| 0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.1 | 0.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 8.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 2.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.5 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.1 | 1.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 2.6 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.1 | 0.1 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 | 0.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 1.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 | 0.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.2 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
| 0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 0.5 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 | 1.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.1 | 1.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 1.3 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.1 | GO:0003207 | cardiac chamber formation(GO:0003207) |
| 0.1 | 1.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.1 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.1 | 0.1 | GO:0032835 | glomerulus development(GO:0032835) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 1.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.2 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.2 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 | 1.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.1 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
| 0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
| 0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.2 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.1 | 0.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) axo-dendritic protein transport(GO:0099640) |
| 0.1 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.1 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.1 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.1 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.3 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
| 0.1 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
| 0.1 | 0.4 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 2.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
| 0.1 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 0.1 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.1 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 | 0.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 | 2.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 6.0 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 0.2 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
| 0.1 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.1 | 0.4 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 | 0.3 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 | 1.9 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.1 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) regulation of protein kinase C signaling(GO:0090036) |
| 0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 0.1 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 0.1 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.1 | 1.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.4 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.0 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
| 0.0 | 0.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.0 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.0 | 0.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.0 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.0 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 1.8 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.0 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.4 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.0 | 0.6 | GO:0005979 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
| 0.0 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.0 | 0.0 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
| 0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 | 0.0 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.0 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 0.0 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.0 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.0 | 1.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 | 0.4 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
| 0.0 | 0.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 | 0.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.0 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.1 | GO:1902261 | regulation of heart looping(GO:1901207) positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.0 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.0 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.0 | 1.7 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 | 0.2 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
| 0.0 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 1.1 | GO:0010470 | regulation of gastrulation(GO:0010470) |
| 0.0 | 0.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.0 | 0.2 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
| 0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 | 0.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.0 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
| 0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 | 0.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
| 0.0 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.0 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.0 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 | 0.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.0 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 1.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.0 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 0.0 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.0 | 0.3 | GO:0003401 | axis elongation(GO:0003401) |
| 0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
| 0.0 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.0 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.4 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.0 | 1.1 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 0.6 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.2 | GO:0046849 | bone remodeling(GO:0046849) |
| 0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.7 | GO:0051384 | response to glucocorticoid(GO:0051384) |
| 0.0 | 0.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 | 0.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.5 | GO:0001708 | cell fate specification(GO:0001708) |
| 0.0 | 0.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.0 | 0.1 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
| 0.0 | 0.1 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
| 0.0 | 0.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.1 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.0 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.0 | 0.0 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.0 | 0.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.0 | 0.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.0 | 0.1 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
| 0.0 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.0 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 | 1.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.2 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 0.0 | 0.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.0 | 0.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 1.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
| 0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.5 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 0.0 | GO:0060438 | trachea development(GO:0060438) |
| 0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.0 | 0.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.0 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 0.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 | 0.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.1 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.0 | 0.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 | 0.1 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.0 | 0.1 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.0 | 0.0 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 1.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.1 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
| 0.0 | 0.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.0 | 0.1 | GO:0050862 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.0 | 0.0 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
| 0.0 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.0 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.0 | 0.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.0 | 0.3 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.0 | GO:0086067 | AV node cell to bundle of His cell communication(GO:0086067) |
| 0.0 | 1.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 | 0.1 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
| 0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 0.0 | 0.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.0 | 0.0 | GO:0043092 | L-amino acid import(GO:0043092) |
| 0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 | 0.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.0 | 0.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
| 0.0 | 0.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.0 | 0.3 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
| 0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 | 0.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.0 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.0 | 0.0 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 | 0.3 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
| 0.0 | 0.1 | GO:0021522 | ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.0 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.0 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 | 0.0 | GO:0001840 | neural plate development(GO:0001840) |
| 0.0 | 0.0 | GO:0043090 | amino acid import(GO:0043090) |
| 0.0 | 0.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.0 | 0.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.0 | 0.4 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
| 0.0 | 0.2 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.0 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
| 0.0 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.0 | 0.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
| 0.0 | 0.1 | GO:0035733 | hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) |
| 0.0 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 0.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 7.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 1.1 | 4.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 1.1 | 7.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 1.1 | 5.3 | GO:0002133 | polycystin complex(GO:0002133) |
| 1.0 | 5.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.0 | 4.8 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.9 | 2.8 | GO:0035101 | FACT complex(GO:0035101) |
| 0.9 | 5.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.9 | 0.9 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.8 | 3.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.8 | 6.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.7 | 3.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.7 | 2.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.7 | 0.7 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.7 | 6.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.7 | 5.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.7 | 4.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.7 | 4.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.7 | 4.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.7 | 2.7 | GO:0043293 | apoptosome(GO:0043293) |
| 0.7 | 8.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.6 | 2.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.5 | 9.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.5 | 3.7 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.5 | 5.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.5 | 1.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.5 | 3.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.5 | 3.4 | GO:0042825 | TAP complex(GO:0042825) |
| 0.5 | 3.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.5 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.5 | 5.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.5 | 2.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.5 | 0.9 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.5 | 16.4 | GO:0038201 | TOR complex(GO:0038201) |
| 0.4 | 3.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.4 | 5.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.4 | 6.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 3.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.4 | 1.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.4 | 6.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 1.1 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.4 | 3.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.4 | 5.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.4 | 1.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.3 | 3.8 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 12.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.3 | 1.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.3 | 1.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.3 | 3.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.3 | 1.0 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.3 | 2.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.3 | 1.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 0.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.3 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 0.9 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.3 | 0.9 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.3 | 1.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 0.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.3 | 1.5 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.3 | 1.2 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.3 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 47.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.3 | 8.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.3 | 0.9 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.3 | 0.9 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.3 | 0.9 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.3 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.3 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.3 | 4.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.3 | 3.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 4.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 2.2 | GO:0097361 | CIA complex(GO:0097361) |
| 0.3 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 20.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 13.3 | GO:0043034 | costamere(GO:0043034) |
| 0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
| 0.3 | 2.0 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 1.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 2.0 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 5.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.2 | 7.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.2 | 1.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.2 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 3.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 1.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.2 | 16.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 1.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.2 | 1.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.2 | 20.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.2 | 0.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.2 | 1.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.2 | 2.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 0.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.2 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 1.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 2.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 1.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.2 | 3.8 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.2 | 2.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 0.8 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.2 | 4.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 1.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 2.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 0.6 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.2 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.2 | 2.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 1.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 2.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.2 | 5.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 2.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 2.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.2 | 0.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.2 | 3.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.2 | 0.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.2 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 3.7 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 4.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.2 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 1.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.2 | 0.8 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.2 | 0.2 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.2 | 0.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.2 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 2.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.2 | 2.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.2 | 0.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.2 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.2 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.2 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.2 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
| 0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 11.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 3.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 10.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 1.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 3.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 3.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.4 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.1 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 5.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 1.3 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.1 | 0.7 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 2.0 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.5 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.1 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.1 | 0.5 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 7.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
| 0.1 | 2.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.1 | 10.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 2.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 1.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 2.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 2.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 1.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 3.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 1.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 0.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.1 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 2.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 0.8 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 1.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 0.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.1 | 1.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.3 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 10.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 6.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 6.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 0.2 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.1 | 0.6 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 4.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 1.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 0.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 1.2 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.9 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.1 | 0.8 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 0.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.1 | 9.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 2.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 45.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.5 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 489.3 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 0.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) clathrin vesicle coat(GO:0030125) |
| 0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.1 | 0.4 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 0.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 5.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 1.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 1.3 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.2 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 2.4 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 3.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.0 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 5.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.0 | 2.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 1.7 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
| 0.0 | 4.8 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
| 0.0 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 1.3 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.0 | 0.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.0 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.9 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 8.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.0 | 3.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 1.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.0 | 0.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.0 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.0 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.0 | 0.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 1.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 0.7 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 1.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.0 | 6.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.1 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
| 0.0 | 0.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.0 | 8.3 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.0 | 0.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 1.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.5 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 2.1 | 6.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.0 | 6.1 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 1.8 | 5.5 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 1.7 | 7.0 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.7 | 15.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.6 | 11.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 1.6 | 4.7 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 1.5 | 13.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 1.4 | 14.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 1.4 | 8.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.4 | 5.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.3 | 6.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.3 | 7.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 1.3 | 5.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 1.2 | 1.2 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 1.1 | 4.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 1.1 | 4.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.1 | 5.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.1 | 3.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 1.1 | 4.4 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.1 | 2.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.1 | 5.4 | GO:0070905 | serine binding(GO:0070905) |
| 1.1 | 4.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 1.0 | 7.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 1.0 | 7.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 1.0 | 1.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.0 | 3.1 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 1.0 | 4.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 1.0 | 2.9 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 1.0 | 2.9 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.9 | 4.7 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.9 | 2.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.9 | 4.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.9 | 3.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.9 | 2.7 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.9 | 3.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.9 | 2.6 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.8 | 6.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.8 | 3.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.8 | 1.7 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 0.8 | 3.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.8 | 3.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.8 | 3.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.8 | 3.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.8 | 4.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.7 | 3.7 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.7 | 3.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.7 | 8.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.7 | 2.9 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.7 | 2.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.7 | 2.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.7 | 2.8 | GO:0004974 | leukotriene B4 receptor activity(GO:0001632) leukotriene receptor activity(GO:0004974) |
| 0.7 | 2.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.7 | 14.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.7 | 2.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.7 | 0.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.7 | 2.0 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.7 | 2.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.6 | 3.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.6 | 2.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.6 | 5.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.6 | 5.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.6 | 1.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.6 | 1.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.6 | 2.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.6 | 0.6 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.6 | 3.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.6 | 7.8 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.6 | 3.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.6 | 14.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.6 | 2.9 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.6 | 2.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.6 | 2.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.6 | 1.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 4.0 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.6 | 3.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.6 | 1.7 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.6 | 7.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.6 | 1.7 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.6 | 1.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.6 | 2.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.6 | 1.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.6 | 2.8 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.6 | 1.7 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.5 | 4.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.5 | 2.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.5 | 2.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.5 | 4.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.5 | 2.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.5 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.5 | 2.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.5 | 3.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.5 | 0.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.5 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.5 | 4.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.5 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.5 | 1.5 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.5 | 2.0 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.5 | 3.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.5 | 2.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 5.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.5 | 3.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.5 | 2.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.5 | 5.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.5 | 3.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.5 | 1.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.5 | 1.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.5 | 5.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.5 | 7.0 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.5 | 8.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.5 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.5 | 10.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.4 | 1.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.4 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.4 | 2.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.4 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.4 | 5.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.4 | 1.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.4 | 6.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.4 | 1.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.4 | 2.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.4 | 0.8 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.4 | 1.3 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.4 | 1.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.4 | 1.2 | GO:0052835 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.4 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.4 | 2.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.4 | 1.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.4 | 3.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.4 | 0.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.4 | 1.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.4 | 1.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.4 | 1.2 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.4 | 1.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.4 | 5.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.4 | 1.9 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.4 | 1.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.4 | 1.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 1.5 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.4 | 1.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.4 | 1.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 1.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.4 | 1.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.4 | 2.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.4 | 1.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.4 | 8.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.4 | 1.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.4 | 0.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.4 | 1.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.4 | 1.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.4 | 1.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.4 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.4 | 1.1 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.4 | 1.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.4 | 1.4 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.4 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.4 | 1.4 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.4 | 0.4 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.4 | 1.8 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 1.0 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.3 | 3.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.3 | 3.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.3 | 1.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.3 | 3.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 3.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 1.0 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.3 | 2.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.3 | 3.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.3 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 7.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.3 | 6.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.3 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.3 | 1.3 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.3 | 3.6 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.3 | 3.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 4.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 11.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.3 | 3.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.3 | 1.0 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.3 | 2.6 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.3 | 4.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 1.3 | GO:0004803 | transposase activity(GO:0004803) |
| 0.3 | 1.0 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.3 | 3.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.3 | 4.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 0.9 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.3 | 0.9 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
| 0.3 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.3 | 3.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.3 | 0.9 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.3 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 1.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.3 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 1.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 1.2 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.3 | 1.5 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.3 | 2.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.3 | 8.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.3 | 0.9 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.3 | 4.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.3 | 3.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.3 | 2.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 1.5 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 2.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.3 | 1.8 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.3 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
| 0.3 | 2.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.3 | 3.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 0.9 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.3 | 4.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.3 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.3 | 2.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.3 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 4.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.3 | 1.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.3 | 2.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.3 | 0.8 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.3 | 1.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.3 | 9.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 5.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 6.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.3 | 3.0 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.3 | 3.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 3.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.3 | 1.6 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.3 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 1.6 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.3 | 2.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.3 | 0.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.3 | 1.1 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.3 | 5.5 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 0.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.3 | 0.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 5.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.3 | 0.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.3 | 1.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.3 | 1.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.3 | 1.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.3 | 0.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.3 | 3.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.3 | 8.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 2.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 1.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.3 | 4.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.3 | 2.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.3 | 3.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.2 | 7.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 10.9 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.2 | 6.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 0.2 | 1.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.2 | 1.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 3.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.2 | 0.2 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 3.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 2.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.2 | 1.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.2 | 2.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 1.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 5.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.2 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 1.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 5.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.2 | 2.3 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.2 | 7.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 9.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.2 | 2.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 1.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.2 | 1.6 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 0.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 1.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.2 | 4.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.2 | 0.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 0.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.2 | 5.8 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.2 | 1.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 5.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.2 | 0.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.2 | 2.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.2 | 0.9 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 2.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.2 | 1.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.2 | 8.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 0.6 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.2 | 0.6 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.2 | 0.8 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.2 | 1.2 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.2 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 2.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 0.6 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.2 | 2.7 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.2 | 4.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 4.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.2 | 0.6 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.2 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.2 | 0.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 2.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.2 | 1.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.2 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 22.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.2 | 0.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.2 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 7.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 1.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 1.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 1.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 0.6 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 3.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.2 | 1.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 0.6 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.2 | 2.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 4.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 2.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 0.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.2 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.2 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.2 | 4.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 3.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.2 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 0.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.2 | 0.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 1.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 0.5 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.2 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 7.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 0.4 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.2 | 1.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 0.4 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.2 | 1.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.2 | 0.5 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 1.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.2 | 13.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.2 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 3.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.2 | 0.5 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.2 | 1.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 0.3 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.2 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 4.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 1.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 4.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 1.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.2 | 5.1 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 1.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 2.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.2 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 1.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.2 | 0.6 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.2 | 0.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.2 | 0.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 1.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.2 | 0.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.2 | 0.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.2 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 1.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 0.5 | GO:0004915 | ciliary neurotrophic factor receptor activity(GO:0004897) interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
| 0.2 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.2 | 0.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.2 | 4.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.2 | 1.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
| 0.2 | 3.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 0.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.2 | 0.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 2.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.2 | 4.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.2 | 6.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 2.4 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.1 | 1.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 0.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 4.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 3.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.6 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.1 | 1.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 0.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 1.0 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.1 | 3.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.4 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 6.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 1.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 2.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 0.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.1 | 0.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 1.7 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 2.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 8.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 1.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 1.4 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 4.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.9 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 1.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 1.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 2.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 1.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 3.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 4.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.6 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.1 | 8.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 3.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 2.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 1.4 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 8.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.1 | 5.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 4.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 4.1 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.1 | 0.3 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.1 | 1.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.1 | 1.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
| 0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.1 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 0.5 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.1 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 1.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 2.5 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 2.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) corticotropin hormone receptor binding(GO:0031780) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) type 5 melanocortin receptor binding(GO:0031783) type 1 melanocortin receptor binding(GO:0070996) |
| 0.1 | 4.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 5.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 1.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.1 | 3.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 1.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.1 | 1.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 0.7 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
| 0.1 | 2.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.1 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 0.6 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
| 0.1 | 0.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 0.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 1.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 1.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.1 | 0.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.1 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 2.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.1 | 2.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.9 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 5.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 1.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 1.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.2 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.1 | 0.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.1 | 0.2 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.1 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 2.8 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.1 | 0.3 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
| 0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 2.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 1.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 1.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.1 | 3.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.1 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.1 | 0.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.1 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.1 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.1 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.1 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 1.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.1 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.0 | 1.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.9 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.0 | 0.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.0 | 0.4 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.0 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 4.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.0 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 0.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.0 | 0.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.3 | GO:0042835 | BRE binding(GO:0042835) |
| 0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.0 | 7.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.0 | 0.1 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.0 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 17.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.0 | 0.5 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 2.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.0 | 0.0 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.0 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
| 0.0 | 0.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.0 | 0.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.0 | 0.5 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
| 0.0 | 0.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.0 | 2.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.0 | 0.1 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.0 | 0.0 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 5.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.1 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.0 | 1.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.1 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.0 | 0.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.0 | 0.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.1 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.0 | 0.1 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
| 0.0 | 6.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.0 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 2.0 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.0 | 9.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.0 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.0 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.0 | 0.3 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
| 0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
| 0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
| 0.0 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.0 | 0.0 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.0 | 0.0 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 0.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.0 | 0.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.0 | 0.0 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 1.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.4 | 8.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 19.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 2.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.3 | 7.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 1.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.3 | 8.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.3 | 2.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 14.0 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 5.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 6.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 12.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 6.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.2 | 6.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 8.0 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 21.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 5.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 26.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 11.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 3.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 4.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 11.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 1.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 4.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 8.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 2.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 4.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 4.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 3.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 6.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 9.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 8.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 1.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 2.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 2.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 3.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 2.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 5.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 5.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 2.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 2.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 2.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 3.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 1.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.0 | 7.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 7.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 10.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.7 | 22.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.6 | 10.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.6 | 15.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 10.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.4 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.4 | 6.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 10.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.4 | 21.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.3 | 8.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.3 | 13.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 4.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.3 | 11.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.3 | 2.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 5.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 5.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.3 | 25.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.3 | 6.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 2.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 0.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.3 | 4.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 4.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 3.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 6.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 4.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 3.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 17.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 5.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 6.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 8.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 3.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.2 | 9.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.2 | 3.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.2 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 3.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 9.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.2 | 7.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 4.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 2.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.2 | 2.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 0.3 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
| 0.2 | 12.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.2 | 1.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 1.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 4.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 12.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 6.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 14.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 2.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 8.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.2 | 3.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 6.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 2.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 4.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 2.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 4.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 4.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 6.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 14.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 8.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 7.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 4.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 2.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 1.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.1 | 0.6 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 0.1 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 1.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 1.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 2.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 0.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.1 | 1.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 5.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 3.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 2.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 2.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.1 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 2.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 6.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 1.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 2.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 3.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 1.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 2.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 4.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 2.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 10.0 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.1 | 3.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 3.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 0.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.0 | 4.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 5.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 3.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 0.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |